Tuesday, November 3, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Samsung Biologics Secures 97.66% of PolyPeptide Shares in Tender Offer

TR

By Tom Reyes · Markets Editor

Nov 2 13:29 ETSource: BioPharm International

From the source

Samsung Biologics Secures 97.66% of PolyPeptide Shares in Tender Offer

Read at biopharminternational.com

Source URL https://www.biopharminternational.com/view/samsung-biologics-polypeptide-tender-offer-provisional-result

Prescribed peptides from $99/moSee all →